|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.40 PLN | +1.18% |
|
-2.43% | -11.60% |
| 27/05 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 15/05 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Innovations in The Field of Diagnostics and Health Protection | - | - | 4L | 5L | 1L | |||||
Total Assets | 4.13Cr | 5.27Cr | 35Cr | 10Cr | 17Cr | |||||
Interest Expense | -25 | -26.1L | -7L | -3L | -2L | |||||
Income Tax Expense | - | -1T | 6.91Cr | 1L | 2Cr | |||||
CAPEX | -5L | -49.1L | -2L | -19.29L | -32.35L | |||||
EBT | -74.21L | -1.17Cr | 40Cr | -1.87Cr | 8.54Cr | |||||
D&A | 10L | 4L | 7L | 10.8L | 15.12L | |||||
Operating Income | -74.34L | -1.02Cr | 39Cr | -2.87Cr | 7.71Cr | |||||
Net Income | -74.21L | -1.66Cr | 32Cr | -1.88Cr | 6.54Cr |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Poland | - | - | 4L | 5L | 1L | |||||
Total Assets | 4.13Cr | 5.27Cr | 35Cr | 10Cr | 17Cr | |||||
Interest Expense | -25 | -26.1L | -7L | -3L | -2L | |||||
Income Tax Expense | - | -1T | 6.91Cr | 1L | 2Cr | |||||
D&A | 10L | 4L | 7L | 10.8L | 15.12L | |||||
CAPEX | -5L | -49.1L | -2L | -19.29L | -32.35L | |||||
Net Income | -74.21L | -1.66Cr | 32Cr | -1.88Cr | 6.54Cr | |||||
EBT | -74.21L | -1.17Cr | 40Cr | -1.87Cr | 8.54Cr | |||||
Operating Income | -74.34L | -1.02Cr | 39Cr | -2.87Cr | 7.71Cr |
- Stock Market
- Stocks
- SCP Stock
- Financials Scope Fluidics S.A.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
